Accessible Colours
Events
News
Europe
Europe
Africa
Asia Pacific
Latin America
MENA
North America
Menu
What we offer
Industries
Charities
Consumer markets
Education
Energy and natural resources
Financial services
Government and public sector
Healthcare
Infrastructure
Life sciences
Manufacturing
Media and technology
Pensions
Professional services
Real estate and construction
Recruitment
Social housing
Services
Audit services
Business transformation
Deal services
Finance function support
Forensic, investigations and disputes
Legal services
People advisory services
Restructuring
Risk and governance
Tax
International business services
Family businesses
Private equity
Insights
Middle Market Business Index
The Real Economy
Tax Voice
The Loop
Media and technology UK industry outlook 2024
Industrial strategy for manufacturers
About RSM
Alumni
Our leadership team
Our reports
The RSM client experience
RSM and golf
Corporate responsibility
Diversity and inclusion
Wellbeing
Working at RSM
Careers
Search
Europe
Europe
Africa
Asia Pacific
Latin America
MENA
North America
Events
News
Contact RSM
Search
Contact RSM
Home
>
insights
>
Health Matters
>
Life Sciences
>
Life Sciences
Our specialists explore the key trends and issues impacting the life sciences sector.
Life Sciences
What is the impact of ESG for life sciences and healthcare businesses?
Steven Radcliffe
,
Graham Bond
16 Aug 2023
Life Sciences
Global mobility and talent retention in life sciences
James Smith
,
Ainsley Wainwright
24 Mar 2023
Life Sciences
Spring budget changes to R&D – impact on the life sciences sector
Lizzie Gosling
,
James Tetley
22 Mar 2023
Life Sciences
What are the key business risks in healthcare and life sciences?
Liz Wright
22 Mar 2023
Life Sciences
Don’t overlook solid foundations for your early-stage life sciences business
Phil Melia
,
Laragh Jeanroy
16 Aug 2022
Life Sciences
Big changes coming for R&D in the life sciences sector
James Tetley
,
Lizzie Gosling
25 Apr 2022
Life Sciences
Tackling R&D abuse – Will your claims still be compliant?
James Tetley
,
Lizzie Gosling
25 Apr 2022
Life Sciences
Restricting R&D relief for expenditure incurred overseas – the impact for life sciences
James Tetley
,
Lizzie Gosling
25 Apr 2022
Life Sciences
PAYE cap for R&D claims – the impact for life sciences
James Tetley
,
Lizzie Gosling
20 Apr 2022
Load next 9 insights (
8
)